Oxytocin
Endogenous nonapeptide hormone and neurotransmitter
- Class
- Neuropeptide hormone
- Half-life
- ~3-20 min
- Route
- Intranasal
- Cadence
- Daily
- Evidence
- Human clinical trials
Overview
Oxytocin is the hormone your body releases during childbirth, breastfeeding, and orgasm — but it also acts as a neurotransmitter in your brain, modulating social cognition, trust, and anxiety. The FDA-approved versions (Pitocin, Syntocinon) are IV drugs for inducing labour and controlling postpartum bleeding. The intranasal form — which is what shows up in research markets — is investigational, not approved anywhere, and aimed at social-cognitive disorders like autism spectrum disorder and social anxiety.
The pitch: intranasal oxytocin might make you better at reading faces, more trusting in social settings, and less anxious around people. Small trials have shown modest improvements in eye contact and social reciprocity in autism, and reduced amygdala reactivity to threatening faces in social anxiety. But the effects are subtle, highly context-dependent, and don't replicate cleanly across studies.
The reality: intranasal delivery is messy. How much actually reaches the brain is unclear — estimates range from trace amounts to ~1%. Most of what you spray ends up swallowed or draining into your throat. The peptide also gets chewed up by enzymes fast. Studies use wildly different doses (8-80 IU per session) and it's not obvious which dose does what, or whether chronic daily use works differently than single-dose acute use.
Safety considerations
A few of the safety signals worth knowing — the full list, with dosing context and what to monitor, is inside AIx Core.
- Not approved for intranasal use in any country. The IV formulations (Pitocin, Syntocinon) are prescription-only for obstetric indications. Intranasal oxytocin sold in research markets is unregulated — purity and actual peptide content are not verified.
- Pregnancy: oxytocin causes uterine contractions. Intranasal use during pregnancy is contraindicated — even small systemic absorption could trigger preterm labour.
- Nasal side effects are common with chronic use: irritation, congestion, occasional nosebleeds. The spray vehicle (usually glycerin or propylene glycol) contributes to this.
+ 3 more safety notes inside AIx Core →
Commonly monitored
Markers and signals people track when researching Oxytocin.
- Subjective social comfort or anxiety in specific settings
- Nasal irritation or nosebleeds (chronic intranasal use)
- Blood pressure (oxytocin can cause mild hypotension)
- Uterine cramping in women (peripheral OXTR activation)
- Changes in trust/suspicion patterns (track both positive and negative shifts)
Frequently asked questions
What is Oxytocin?
Endogenous nonapeptide hormone and neurotransmitter. Oxytocin is the hormone your body releases during childbirth, breastfeeding, and orgasm — but it also acts as a neurotransmitter in your brain, modulating social cognition, trust, and anxiety. The FDA-approved versions (Pitocin, Syntocinon) are IV drugs for inducing labour and controlling postpartum bleeding. The intranasal form — which is what shows up in research markets — is investigational, not approved anywhere, and aimed at social-cognitive disorders like autism spectrum disorder and social anxiety.
How is Oxytocin administered?
Intranasal, typically daily.
What is the half-life of Oxytocin?
~3-20 min — Extremely short in blood; intranasal effects may last hours via CNS pathways.
Is Oxytocin approved for human use?
Oxytocin is investigational — not approved by the FDA, EMA, or MHRA for human use at the time of writing.
What does the evidence show for Oxytocin?
Evidence tier: Human clinical trials. Guastella et al. 2010 (N=16 ASD adults, 18 IU intranasal OT vs placebo, crossover): improved emotion recognition accuracy and increased gaze to the eye region during a face-processing task. Effect size modest (Cohen's d ~0.5).
What is commonly monitored when researching Oxytocin?
Commonly tracked markers + signals: Subjective social comfort or anxiety in specific settings, Nasal irritation or nosebleeds (chronic intranasal use), Blood pressure (oxytocin can cause mild hypotension), Uterine cramping in women (peripheral OXTR activation), Changes in trust/suspicion patterns (track both positive and negative shifts).
Open this in AIx Core for the full picture
Mechanism breakdown, receptor pathway diagram, full safety list, monitored items, source citations, and one-tap add-to-protocol. Free with any account.